{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T10:22:37Z","timestamp":1782210157704,"version":"3.54.5"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T00:00:00Z","timestamp":1723075200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.canlet.2024.217151","type":"journal-article","created":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:11:31Z","timestamp":1722471091000},"page":"217151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Reduced PTPRS expression promotes epithelial-mesenchymal transition of Schwann cells in NF1-related plexiform neurofibromas"],"prefix":"10.1016","volume":"599","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0227-5310","authenticated-orcid":false,"given":"Yuehua","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengjiang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manhon","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beiyao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zizhen","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihui","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingfeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5859-4193","authenticated-orcid":false,"given":"Zhichao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.canlet.2024.217151_bib1","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1172\/JCI99424","article-title":"Contributions of inflammation and tumor microenvironment to neurofibroma tumorigenesis","volume":"128","author":"Liao","year":"2018","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.canlet.2024.217151_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1227\/01.NEU.0000190651.45384.8B","article-title":"Molecular, genetic, and cellular pathogenesis of neurofibromas and surgical implications","volume":"58","author":"Gottfried","year":"2006","journal-title":"Neurosurgery"},{"issue":"12","key":"10.1016\/j.canlet.2024.217151_bib3","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1093\/neuonc\/noy067","article-title":"Association of plexiform neurofibroma volume changes and development of clinical morbidities in neurofibromatosis 1","volume":"20","author":"Gross","year":"2018","journal-title":"Neuro Oncol."},{"issue":"26","key":"10.1016\/j.canlet.2024.217151_bib4","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1056\/NEJMoa1605943","article-title":"Activity of selumetinib in neurofibromatosis type 1-related plexiform neurofibromas","volume":"375","author":"Dombi","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.canlet.2024.217151_bib5","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/BPO.0b013e31820cad77","article-title":"Resection of plexiform neurofibromas in children with neurofibromatosis type 1","volume":"31","author":"Canavese","year":"2011","journal-title":"J. Pediatr. Orthop."},{"issue":"9","key":"10.1016\/j.canlet.2024.217151_bib6","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/gim.2013.30","article-title":"Growth behavior of plexiform neurofibromas after surgery","volume":"15","author":"Nguyen","year":"2013","journal-title":"Genet. Med."},{"issue":"3","key":"10.1016\/j.canlet.2024.217151_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1589","article-title":"Safety, pharmacokinetics and efficacy of selumetinib in Chinese adult and paediatric patients with neurofibromatosis type 1 and inoperable plexiform neurofibromas: the primary analysis of a phase 1 open-label study","volume":"14","author":"Wang","year":"2024","journal-title":"Clin. Transl. Med."},{"issue":"2","key":"10.1016\/j.canlet.2024.217151_bib8","first-page":"289","article-title":"Phase II trial of pegylated interferon alfa-2b in young patients with neurofibromatosis type 1 and unresectable plexiform neurofibromas","volume":"19","author":"Jakacki","year":"2017","journal-title":"Neuro Oncol."},{"issue":"3","key":"10.1016\/j.canlet.2024.217151_bib9","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.jid.2018.09.016","article-title":"Absence of efficacy of everolimus in neurofibromatosis 1-related plexiform neurofibromas: results from a phase 2a trial","volume":"139","author":"Zehou","year":"2019","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.canlet.2024.217151_bib10","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrc2980","article-title":"Inside the human cancer tyrosine phosphatome","volume":"11","author":"Julien","year":"2011","journal-title":"Nat. Rev. Cancer"},{"issue":"23","key":"10.1016\/j.canlet.2024.217151_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222312865","article-title":"Protein tyrosine phosphatases: mechanisms in cancer","volume":"22","author":"Sivaganesh","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.canlet.2024.217151_bib12","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.cell.2004.05.018","article-title":"Protein tyrosine phosphatases in the human genome","volume":"117","author":"Alonso","year":"2004","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.canlet.2024.217151_bib13","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/jnr.10382","article-title":"Protein tyrosine phosphatase sigma-deficient mice show aberrant cytoarchitecture and structural abnormalities in the central nervous system","volume":"70","author":"Meathrel","year":"2002","journal-title":"J. Neurosci. Res."},{"issue":"5952","key":"10.1016\/j.canlet.2024.217151_bib14","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1126\/science.1178310","article-title":"PTPsigma is a receptor for chondroitin sulfate proteoglycan, an inhibitor of neural regeneration","volume":"326","author":"Shen","year":"2009","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.canlet.2024.217151_bib15","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1002\/mc.23720","article-title":"Loss of PTPRS elicits potent metastatic capability and resistance to temozolomide in glioblastoma","volume":"63","author":"Zhang","year":"2024","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.canlet.2024.217151_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.582220","article-title":"Protein tyrosine phosphatase receptor S acts as a metastatic suppressor in malignant peripheral nerve sheath tumor via profilin 1-induced epithelial-mesenchymal transition","volume":"8","author":"Ren","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.canlet.2024.217151_bib17","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/hep.28350","article-title":"Protein tyrosine phosphatase receptor S acts as a metastatic suppressor in hepatocellular carcinoma by control of epithermal growth factor receptor-induced epithelial-mesenchymal transition","volume":"63","year":"2016","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.canlet.2024.217151_bib18","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jpeds.2011.08.051","article-title":"Pediatric plexiform neurofibromas: impact on morbidity and mortality in neurofibromatosis type 1","volume":"160","author":"Prada","year":"2012","journal-title":"J. Pediatr."},{"issue":"4","key":"10.1016\/j.canlet.2024.217151_bib19","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jpeds.2011.04.008","article-title":"Plexiform neurofibromas in children with neurofibromatosis type 1: frequency and associated clinical deficits","volume":"159","author":"Nguyen","year":"2011","journal-title":"J. Pediatr."},{"issue":"10","key":"10.1016\/j.canlet.2024.217151_bib20","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1093\/neuonc\/noad086","article-title":"Long-term safety and efficacy of selumetinib in children with neurofibromatosis type 1 on a phase 1\/2 trial for inoperable plexiform neurofibromas","volume":"25","author":"Gross","year":"2023","journal-title":"Neuro Oncol."},{"issue":"2","key":"10.1016\/j.canlet.2024.217151_bib21","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s10072-021-05361-5","article-title":"Epidemiological and clinical burden associated with plexiform neurofibromas in pediatric neurofibromatosis type-1 (NF-1): a systematic literature review","volume":"43","author":"Iheanacho","year":"2022","journal-title":"Neurol. Sci."},{"issue":"5","key":"10.1016\/j.canlet.2024.217151_bib22","first-page":"937","article-title":"Shedding new light: novel therapies for common disorders in children with neurofibromatosis type I","volume":"70","author":"Pillay-Smiley","year":"2023","journal-title":"Pediatr. Clin."},{"issue":"12","key":"10.1016\/j.canlet.2024.217151_bib23","doi-asserted-by":"crossref","first-page":"5024","DOI":"10.1523\/JNEUROSCI.22-12-05024.2002","article-title":"Chick PTPsigma regulates the targeting of retinal axons within the optic tectum","volume":"22","author":"Rashid-Doubell","year":"2002","journal-title":"J. Neurosci."},{"issue":"47","key":"10.1016\/j.canlet.2024.217151_bib24","doi-asserted-by":"crossref","first-page":"19024","DOI":"10.1073\/pnas.1111963108","article-title":"Genomic dissection of the epidermal growth factor receptor (EGFR)\/PI3K pathway reveals frequent deletion of the EGFR phosphatase PTPRS in head and neck cancers","volume":"108","author":"Morris","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"63","key":"10.1016\/j.canlet.2024.217151_bib25","doi-asserted-by":"crossref","first-page":"6768","DOI":"10.18632\/oncotarget.27335","article-title":"PTPRS drives adaptive resistance to MEK\/ERK inhibitors through SRC","volume":"10","author":"Davis","year":"2019","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.canlet.2024.217151_bib26","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1002\/1878-0261.13500","article-title":"Activation of the EGFR\/PI3K\/AKT pathway limits the efficacy of trametinib treatment in head and neck cancer","volume":"17","author":"Novoplansky","year":"2023","journal-title":"Mol. Oncol."},{"issue":"Suppl 4","key":"10.1016\/j.canlet.2024.217151_bib27","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0959-8049(01)00230-1","article-title":"The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities","volume":"37","author":"Yarden","year":"2001","journal-title":"Eur. J. Cancer"},{"issue":"12","key":"10.1016\/j.canlet.2024.217151_bib28","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1038\/onc.2016.386","article-title":"EGFR-Stat3 signalling in nerve glial cells modifies neurofibroma initiation","volume":"36","author":"Wu","year":"2017","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.canlet.2024.217151_bib29","first-page":"137","article-title":"Vascular endothelial growth factor, basic fibroblast growth factor and epithelial growth factor receptor in peripheral nerve sheath tumors of neurofibromatosis type 1","volume":"35","author":"Friedrich","year":"2015","journal-title":"Anticancer Res."},{"issue":"8","key":"10.1016\/j.canlet.2024.217151_bib30","doi-asserted-by":"crossref","first-page":"e136","DOI":"10.1111\/j.1600-0625.2009.01017.x","article-title":"Decreased expression of neurofibromin contributes to epithelial-mesenchymal transition in neurofibromatosis type 1","volume":"19","author":"Arima","year":"2010","journal-title":"Exp. Dermatol."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383524005469?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383524005469?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T15:22:21Z","timestamp":1724426541000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383524005469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":30,"alternative-id":["S0304383524005469"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2024.217151","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduced PTPRS expression promotes epithelial-mesenchymal transition of Schwann cells in NF1-related plexiform neurofibromas","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2024.217151","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"217151"}}